{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:59:25Z","timestamp":1769731165191,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2022M720523"],"award-info":[{"award-number":["2022M720523"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141205"],"award-info":[{"award-number":["82141205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jpba.2024.116649","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T04:12:42Z","timestamp":1735013562000},"page":"116649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of anti-SARS-CoV-2 compounds from Qingwen Zhike prescription and exploration of their underlying mechanism by UPLC-Q-Exactive Orbitrap MS, high-throughput screening assays and transmission electron microscopy"],"prefix":"10.1016","volume":"255","author":[{"given":"Ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianli","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116649_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2024.116649_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ptr.7669","article-title":"Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Jin","year":"2023","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jpba.2024.116649_bib3","first-page":"5","article-title":"Discussion on Corona Virus Disease 2019 Treated by Traditional Chinese Medicine Based on Data Mining and Treatment of Different Diseases, Chinese Arch","volume":"38","author":"Feng","year":"2020","journal-title":"Tradit. Chin. Med."},{"key":"10.1016\/j.jpba.2024.116649_bib4","first-page":"1","article-title":"Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116649_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.790072","article-title":"Qingwenzhike prescription alleviates acute lung injury induced by LPS via inhibiting TLR4\/NF-kB pathway and NLRP3 inflammasome activation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116649_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jpba.2024.116649_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model","volume":"133","author":"Fan","year":"2020","journal-title":"Chin. Med. J. (Engl. )."},{"key":"10.1016\/j.jpba.2024.116649_bib8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s43440-020-00132-z","article-title":"Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19","volume":"72","author":"Rogosnitzky","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpba.2024.116649_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2024.07.007","article-title":"Sanhan huashi formula and its bioactive compounds exert antiviral and anti-inflammatory effects on COVID-19","author":"Tian","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.jpba.2024.116649_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301775120","article-title":"Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19","volume":"120","author":"Xu","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2024.116649_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.apsb.2020.10.002","article-title":"Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.jpba.2024.116649_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bsheal.2021.07.003","article-title":"SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review","volume":"3","author":"Muhammed","year":"2021","journal-title":"Biosaf. Heal."},{"key":"10.1016\/j.jpba.2024.116649_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","article-title":"Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpba.2024.116649_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jpba.2024.116649_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12985-023-01969-5","article-title":"Ethanol extract from Artemisia argyi leaves inhibits HSV-1 infection by destroying the viral envelope","volume":"20","author":"Liu","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.jpba.2024.116649_bib16","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.2174\/0929867328666210218182203","article-title":"Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target","volume":"28","author":"Palombi","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2024.116649_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/function\/zqaa002","article-title":"Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection","volume":"1","author":"O\u2019donnell","year":"2020","journal-title":"Function"},{"key":"10.1016\/j.jpba.2024.116649_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100208","article-title":"The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses","volume":"63","author":"Saud","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2024.116649_bib19","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1021\/acs.accounts.1c00300","article-title":"Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms down to the Single Particle Level","volume":"54","author":"Park","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jpba.2024.116649_bib20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/ijms23042060","article-title":"Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs","volume":"23","author":"Zannella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116649_bib21","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpba.2024.116649_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jep.2012.05.061","article-title":"Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus","volume":"143","author":"Hsieh","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2024.116649_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2024.116649_bib24","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1039\/C7CP08573G","article-title":"Self-assembly of chiral (1: R,2 S)-ephedrine and (1 S,2 S)-pseudoephedrine into low-dimensional aluminophosphate materials driven by their amphiphilic nature","volume":"20","author":"Bernardo-Maestro","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jpba.2024.116649_bib25","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1080\/21655979.2021.1997261","article-title":"Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19","volume":"12","author":"Daverey","year":"2021","journal-title":"Bioengineered"},{"issue":"9","key":"10.1016\/j.jpba.2024.116649_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0204908","article-title":"Inactivation of human and avian influenza viruses by potassium oleate of natural soap component through exothermic interaction","volume":"13","author":"Kawahara","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2024.116649_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acs.jpcb.3c05531","article-title":"Disruption mechanisms of enveloped viruses by ionic and nonionic surfactants","volume":"128","author":"Negi","year":"2024","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.jpba.2024.116649_bib28","series-title":"Chinese Medicinal Chemistry","author":"Haixue","year":"2011"},{"key":"10.1016\/j.jpba.2024.116649_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103580","article-title":"A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens","volume":"134","author":"Tariq","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jpba.2024.116649_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104620","article-title":"An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses","volume":"152","author":"Wani","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jpba.2024.116649_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/d12050175","article-title":"Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19","volume":"12","author":"Wink","year":"2020","journal-title":"Diversity"},{"key":"10.1016\/j.jpba.2024.116649_bib32","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.3390\/molecules27227893","article-title":"Essential Oils and COVID-19","volume":"27","author":"Elsebai","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2024.116649_bib33","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:19:36Z","timestamp":1769689176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"alternative-id":["S0731708524006915"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116649","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of anti-SARS-CoV-2 compounds from Qingwen Zhike prescription and exploration of their underlying mechanism by UPLC-Q-Exactive Orbitrap MS, high-throughput screening assays and transmission electron microscopy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116649"}}